Identification and validation of GIMAP family genes as immune-related prognostic biomarkers in lung adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Yanyan,Zhang ^[1] ; Shan,Liu ^[2] ; Deyi,Liu ^[3] ; Zhuxiang,Zhao ^[1] ; Haifeng,Song ^[4] ; Kunwei,Peng ^[5]

作者单位： Department of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China. ^[1] Department of Cardiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Cardiovascular Disease, Guangzhou, Guangdong, China. ^[2] Department of General Practice, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. ^[3] Department of Oncology, Lianzhou People's Hospital, Lianzhou, Guangdong, China. ^[4] Guangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy & Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumour Microenvironment, Department of Oncology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. ^[5]

关键词 GIMAP Immunotherapy Lung adenocarcinoma Prognostic Tumor microenvironment

DOI 10.1016/j.heliyon.2024.e33111

PMID 38948046

发布时间 2024-07-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Heliyon

2024年10卷12期

e33111页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Identification and validation of GIMAP family genes as immune-related prognostic biomarkers in lung adenocarcinoma.

Heliyon

相似文献

Heliyon

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Identification and validation of GIMAP family genes as immune-related prognostic biomarkers in lung adenocarcinoma.

Heliyon

相似文献

Heliyon

相关期刊

检索历史清除